rs2228001 — XPC Lys939Gln

XPC Lys939Gln — Your DNA Repair Scanner and Exercise Recovery Capacity

Every day your cells experience thousands of DNA lesions from sunlight, environmental chemicals, and the byproducts of normal metabolism. The protein encoded by XPC is the first responder in the global genome nucleotide excision repair pathway¹¹ global genome nucleotide excision repair pathway
GG-NER scans the entire genome for bulky DNA lesions such as UV-induced cyclobutane pyrimidine dimers and oxidative adducts, initiating repair before damage becomes heritable mutations. XPC acts as the damage sensor: it recognizes the structural distortion created when DNA strands are bent or separated by a lesion, recruits the repair machinery, and initiates the removal of a 25–30 nucleotide damaged oligonucleotide. Without functional XPC, cells in your muscles, skin, and internal organs accumulate DNA lesions that would otherwise be corrected within hours.

The rs2228001 variant (Lys939Gln, also written 939A>C in the literature) is a common missense substitution in XPC codon 939. The ancestral Lys939 allele (T on the plus strand, found in ~60% of the global population) maintains efficient damage recognition. The derived Gln939 allele (G on the plus strand, ~40% globally) subtly alters the protein's conformation at a functionally important region, reducing how efficiently XPC identifies and responds to DNA damage.

The Mechanism

XPC protein contains three major domains: a transglutaminase-like domain, a beta-hairpin domain that inserts into damaged DNA, and a C-terminal domain that recruits TFIIH for strand unwinding. Codon 939 sits within the C-terminal interaction domain²² Codon 939 sits within the C-terminal interaction domain
The C-terminal region of XPC directly contacts TFIIH subunit p62/GTF2H1 and is required for full assembly of the pre-incision NER complex. The Lys→Gln substitution replaces a positively charged lysine with an uncharged glutamine, altering local electrostatic interactions. Functional studies of XPC carriers show that individuals with the Gln939 allele have measurably reduced DNA repair capacity³³ measurably reduced DNA repair capacity
Ex vivo studies using host-cell reactivation assays show Gln939 carriers repair UV-damaged reporter plasmids less efficiently than Lys939 homozygotes compared to Lys939 homozygotes. The effect is dose-dependent: one Gln allele causes moderate reduction; two copies cause the most pronounced deficit.

In the context of exercise, this matters because intense physical activity generates reactive oxygen species that damage DNA⁴⁴ reactive oxygen species that damage DNA
Muscle contraction substantially increases mitochondrial ROS production; these oxidants generate 8-oxoguanine and other bulky adducts in both nuclear and mitochondrial DNA of muscle fibers. The NER pathway — including XPC — is required to process bulky oxidative adducts that base excision repair cannot handle alone. Carriers of the Gln939 allele have a slower initial damage recognition step, meaning exercise-generated DNA lesions persist longer in muscle cells before repair initiates. Over repeated training cycles, this difference in repair kinetics may contribute to delayed recovery and greater susceptibility to cumulative genotoxic stress.

The Evidence

The most comprehensive evidence comes from a meta-analysis of 62 case-control studies⁵⁵ meta-analysis of 62 case-control studies
He et al. International Journal of Cancer 2013 — 25,708 cancer cases and 30,432 controls from published literature. Gln/Gln homozygotes (plus-strand GG) had 16% higher overall cancer risk (OR=1.16, 95% CI 1.07–1.25, p<0.001) compared to Lys/Lys carriers. The effect was stronger under a recessive model (OR=1.14, 95% CI 1.06–1.22) than a dominant model (OR=1.06), suggesting the highest risk accumulates in homozygous carriers. Cancer-specific analysis revealed elevated risk for bladder cancer, lung cancer, and colorectal cancer, with larger effects in Asian populations than Caucasians.

For bladder cancer specifically, a Tunisian case-control study⁶⁶ Tunisian case-control study
Rouissi et al. BMC Cancer 2011 — 193 newly diagnosed bladder tumor cases found that homozygous carriers of the Gln939 (risk) genotype had more than double the bladder cancer risk (OR=2.09, 95% CI 1.09–3.99). Bladder cancer is a NER-relevant malignancy because the urothelium is exposed to carcinogens excreted in urine, and efficient NER is essential for processing the resulting bulky DNA adducts.

For UV-related skin damage, the variant interacts with other XPC haplotype elements. A Polish case-control study in melanoma⁷⁷ Polish case-control study in melanoma
Paszkowska-Szczur K et al. International Journal of Cancer 2013 — 714 melanoma cases and 1,841 healthy controls found that XPC and XPD polymorphisms were associated with melanoma susceptibility in a Polish cohort, with certain XPC haplotypes showing decreased melanoma risk, underscoring that Lys939 is the protective allele. (Note: the specific OR=0.26 figure cited previously could not be confirmed from the published abstract and has been removed pending full-text verification.)

Environmental carcinogen interactions have also been documented. In a study of 958 oral cancer patients from Taiwan⁸⁸ study of 958 oral cancer patients from Taiwan
Wu CN et al. Cancer Genomics Proteomics 2021, carriers of the Gln939 allele (C in paper notation, G on plus strand) showed significantly higher frequencies among cancer cases than controls, and the Gln939 allele was explicitly associated with decreased DNA repair capacity. The interaction with tobacco smoking and betel quid chewing (major sources of bulky DNA adducts in Asian populations) was significant — meaning the repair deficit is amplified when exposure to genotoxins is high.

In the context of radiotherapy, a Polish study of 79 head and neck cancer patients⁹⁹ a Polish study of 79 head and neck cancer patients
Kaminska et al. Reports of Practical Oncology and Radiotherapy 2024 found that rs2228001 genotype correlated with early skin reaction severity and elevated C-reactive protein during treatment, consistent with differential DNA damage processing kinetics in tissues receiving therapeutic ionizing radiation.

Practical Implications

For most carriers, the practical consequence of the Gln939 allele is not dramatic on its own — it is a low-to-moderate penetrance variant that modulates cancer susceptibility over decades of cumulative exposure, not a switch that determines whether cancer develops. The most actionable implications operate in three domains:

Sun and UV exposure: Reduced NER efficiency means UV-induced cyclobutane pyrimidine dimers persist longer in skin cells. This is directly relevant to skin cancer risk and makes consistent sun protection more important for Gln939 carriers.

Exercise recovery: Gln939 carriers have slower initial DNA damage recognition in response to exercise-generated oxidative stress. While no clinical exercise trials have directly measured recovery differences by rs2228001 genotype, the biological mechanism is plausible and supported by the broader literature on NER capacity and genotoxic stress tolerance. Adequate rest between high-intensity sessions and antioxidant micronutrient support (vitamins C, E, and selenium as NER cofactors) may be particularly relevant.

Environmental carcinogen exposure: Smokers and those with significant occupational or dietary carcinogen exposures derive greater absolute benefit from reducing those exposures compared to high-repair-capacity individuals, because Gln939 carriers have less buffer to handle the additional damage burden.

Interactions

XPC operates in a molecular sequence with XPA (rs1800975): XPC performs the initial damage recognition in global-genome NER, then hands off to XPA for damage verification and repair complex assembly. Carriers of impaired alleles at both rs2228001 (XPC recognition) and rs1800975 (XPA verification) may have compounded NER deficiency — damage that XPC detects less efficiently will also be verified less efficiently by XPA, potentially resulting in greater repair delays than either variant produces alone. This XPC–XPA interaction has not been formally quantified in large-scale studies but is biologically predicted from their sequential roles in the NER pathway.

ERCC2/XPD (rs13181) unwinds the DNA duplex around the lesion after XPC recognition and XPA verification. Individuals carrying impaired alleles at all three positions (XPC + XPA + XPD) would theoretically have the most compromised NER. The second common XPC variant rs2228000 (Ala499Val) operates in the same damage recognition domain; combined analysis of rs2228001 and rs2228000 genotypes provides a more complete picture of XPC function than either alone.